8-131015569-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_001115.3(ADCY8):c.960+23805C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0255 in 152,192 control chromosomes in the GnomAD database, including 57 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.026 ( 57 hom., cov: 32)
Consequence
ADCY8
NM_001115.3 intron
NM_001115.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.403
Publications
2 publications found
Genes affected
ADCY8 (HGNC:239): (adenylate cyclase 8) Adenylate cyclase is a membrane bound enzyme that catalyses the formation of cyclic AMP from ATP. The enzymatic activity is under the control of several hormones, and different polypeptides participate in the transduction of the signal from the receptor to the catalytic moiety. Stimulatory or inhibitory receptors (Rs and Ri) interact with G proteins (Gs and Gi) that exhibit GTPase activity and they modulate the activity of the catalytic subunit of the adenylyl cyclase [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0255 (3884/152192) while in subpopulation NFE AF = 0.0397 (2699/67970). AF 95% confidence interval is 0.0385. There are 57 homozygotes in GnomAd4. There are 1862 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3884 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ADCY8 | NM_001115.3 | c.960+23805C>G | intron_variant | Intron 1 of 17 | ENST00000286355.10 | NP_001106.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0255 AC: 3884AN: 152074Hom.: 57 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3884
AN:
152074
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0255 AC: 3884AN: 152192Hom.: 57 Cov.: 32 AF XY: 0.0250 AC XY: 1862AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
3884
AN:
152192
Hom.:
Cov.:
32
AF XY:
AC XY:
1862
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
284
AN:
41550
American (AMR)
AF:
AC:
166
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
121
AN:
3472
East Asian (EAS)
AF:
AC:
2
AN:
5190
South Asian (SAS)
AF:
AC:
121
AN:
4826
European-Finnish (FIN)
AF:
AC:
420
AN:
10580
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2699
AN:
67970
Other (OTH)
AF:
AC:
57
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
195
390
584
779
974
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
34
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.